Tarun Chakravarty
Overview
Explore the profile of Tarun Chakravarty including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
192
Citations
3754
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nagasaka T, Patel V, Suruga K, Shechter A, Koren O, Chakravarty T, et al.
J Am Heart Assoc
. 2025 Feb;
14(4):e037168.
PMID: 39950429
Background: Valve-in-valve transcatheter aortic valve replacement (TAVR) is a recognized alternative for treating the structural valve deterioration of bioprosthetic valves. Recent guidelines and trials have expanded the indications for TAVR...
2.
Shechter A, Gupta A, Kaewkes D, Taheri H, Nagasaka T, Patel V, et al.
Am Heart J
. 2025 Jan;
282:70-80.
PMID: 39755327
Background: Little is known about transcatheter edge-to-edge repair (TEER) for mitral regurgitation (MR) that is performed outside of usual working hours. We aimed to explore the prevalence, correlates, and outcomes...
3.
Shechter A, Taheri H, Nagasaka T, Gupta A, Kaewkes D, Patel V, et al.
J Am Heart Assoc
. 2024 Nov;
13(23):e037635.
PMID: 39575719
Background: Prognostically meaningful tricuspid regurgitation (TR) is not well-defined in the mitral transcatheter edge-to-edge repair arena. We aimed to explore the prevalence, correlates, and consequences of TR grades and postprocedural...
4.
Kaewkes D, Shechter A, Patel V, Koren O, Koseki K, Chakravarty T, et al.
Catheter Cardiovasc Interv
. 2024 Nov;
104(7):1479-1490.
PMID: 39482875
Background: An enhanced classification of primary mitral regurgitation (PMR) based on extramitral cardiac involvement may refine patient selection and optimize the timing of transcatheter edge-to-edge repair (TEER). Aims: This study...
5.
Nagasaka T, Patel V, Shechter A, Suruga K, Koren O, Chakravarty T, et al.
JACC Cardiovasc Interv
. 2024 Sep;
17(17):2023-2037.
PMID: 39260960
Background: Research on the role of transcatheter heart valve (THV) deformation and calcium distribution in patients with bicuspid aortic valves (BAVs) undergoing transcatheter aortic valve replacement (TAVR) remains limited. Objectives:...
6.
Zahr F, Elmariah S, Vemulapalli S, Kodali S, Hahn R, Anderson A, et al.
JACC Cardiovasc Interv
. 2024 Aug;
17(16):1916-1931.
PMID: 39197990
Background: Tricuspid regurgitation (TR) is highly prevalent in the transcatheter aortic valve replacement (TAVR) population, but clear management guidelines are lacking. Objectives: The aims of this study were to elucidate...
7.
Ahmad Y, Oakley L, Yoon S, Kaewkes D, Chakravarty T, Patel C, et al.
J Soc Cardiovasc Angiogr Interv
. 2024 Aug;
1(4):100347.
PMID: 39131939
Background: Coronary obstruction following transcatheter aortic valve replacement (TAVR) is a life-threatening complication. For patients at elevated risk, it is not known how valve choice is influenced by clinical and...
8.
Fontana G, Bedogni F, Groh M, Smith D, Chehab B, Garrett Jr H, et al.
J Soc Cardiovasc Angiogr Interv
. 2024 Aug;
2(2):100562.
PMID: 39129811
Background: The FlexNav delivery system (DS) features a hydrophilic coating, stability layer, and integrated sheath to facilitate valve deployment in vessel diameters ≥5.0 mm. Methods: Data were pooled from 2...
9.
Nagasaka T, Shechter A, Patel V, Koren O, Chakravarty T, Cheng W, et al.
Am J Cardiol
. 2024 Jun;
224:46-54.
PMID: 38844194
Residual significant mitral regurgitation (MR) can increase the risk of adverse events after transcatheter aortic valve replacement (TAVR). The clinical benefits of staged transcatheter edge-to-edge repair (TEER) after TAVR remain...
10.
Chakravarty T, Makar M, Jilaihawi H
Cardiovasc Revasc Med
. 2024 Jun;
65:8-9.
PMID: 38834411
No abstract available.